The FDA approved Miplyffa for the treatment of Niemann-Pick disease.
1 report, 0 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA approved Miplyffa for the treatment of Niemann-Pick disease.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- The FDA is reviewing a drug approval application for a condition involving the company GAD.
- A clinical study led by Dr. Swee Lay Thein is underway at the National Institutes of Health and is subject to oversight by the Food and Drug Administration.
- Intellia Therapeutics is seeking FDA approval for its drug Lonvo-Z.
- A product, NitroMist®, requires FDA approval for sale, and distributor access is being established for federal supply channels.
Coverage
Newest first; wire copies grouped- Unknown outlet